Wu Y - Search Results

1

A network pharmacology-based study to investigate the mechanism of curcumin-regulated regenerative repair of quadriceps femoris muscle in KOA rats.

Ye H, Li ZQ, Yang JM, Long Y, Zhong YB, Wu Y, Wang MY. Ye H, et al. Among authors: wu y. Eur J Pharmacol. 2024 Nov 5;982:176910. doi: 10.1016/j.ejphar.2024.176910. Epub 2024 Aug 17. Eur J Pharmacol. 2024. PMID: 39154821 Free article.

2

Curcumin-activated Wnt5a pathway mediates Ca²⁺ channel opening to affect myoblast differentiation and skeletal muscle regeneration.

Wang MY, Yang JM, Wu Y, Li H, Zhong YB, Luo Y, Xie RL. Wang MY, et al. Among authors: wu y. J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):1834-1849. doi: 10.1002/jcsm.13535. Epub 2024 Jul 10. J Cachexia Sarcopenia Muscle. 2024. PMID: 38982896 Free PMC article.

3

Resveratrol as a potential therapeutic agent for sarcopenic obesity: Insights from in vivoperiments.

Long Y, Wu Y, Zhong Y, Wu Y, Ye H, Luo Y, Xiao L, Ma Y, Wang M. Long Y, et al. Among authors: wu y. Biomed Pharmacother. 2024 Oct;179:117396. doi: 10.1016/j.biopha.2024.117396. Epub 2024 Sep 4. Biomed Pharmacother. 2024. PMID: 39236475 Free article.

4

Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer's disease analyzed by network pharmacology and molecular docking prediction.

Wang S, Ma Y, Huang Y, Hu Y, Huang Y, Wu Y. Wang S, et al. Among authors: wu y. Front Aging Neurosci. 2022 Dec 8;14:1052249. doi: 10.3389/fnagi.2022.1052249. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36570530 Free PMC article.

5

Feasibility study on the use of "Qi-tonifying medicine compound" as an anti-fatigue functional food ingredient based on network pharmacology and molecular docking.

Wu Y, Ma Y, Cao J, Xie R, Chen F, Hu W, Huang Y. Wu Y, et al. Front Nutr. 2023 May 5;10:1131972. doi: 10.3389/fnut.2023.1131972. eCollection 2023. Front Nutr. 2023. PMID: 37215213 Free PMC article.

6

Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer's disease.

Xie R, Chen F, Ma Y, Hu W, Zheng Q, Cao J, Wu Y. Xie R, et al. Among authors: wu y. Front Pharmacol. 2023 Oct 19;14:1249632. doi: 10.3389/fphar.2023.1249632. eCollection 2023. Front Pharmacol. 2023. PMID: 37927608 Free PMC article.

7

GraphkmerDTA: integrating local sequence patterns and topological information for drug-target binding affinity prediction and applications in multi-target anti-Alzheimer's drug discovery.

Zhang Z, Luo G, Ma Y, Wu Z, Peng S, Chen S, Wu Y. Zhang Z, et al. Among authors: wu y, wu z. Mol Divers. 2025 Jan 10. doi: 10.1007/s11030-024-11065-7. Online ahead of print. Mol Divers. 2025. PMID: 39792322

8

ComNet: A Multiview Deep Learning Model for Predicting Drug Combination Side Effects.

Zhang Z, Liu F, Shang X, Chen S, Zuo F, Wu Y, Long D. Zhang Z, et al. Among authors: wu y. J Chem Inf Model. 2025 Jan 3. doi: 10.1021/acs.jcim.4c01737. Online ahead of print. J Chem Inf Model. 2025. PMID: 39749659

9

Anticonvulsive activity of duloxetine: A new choice for the epileptic patients with depression.

Wu Y, Huang Y, Song M, Zhang Z, Liang Z, Deng X. Wu Y, et al. Pak J Pharm Sci. 2019 May;32(3):997-1003. Pak J Pharm Sci. 2019. PMID: 31278712

10

Synthesis, radiolabeling, and evaluation of 68Ga-labeled aminoquinoxaline derivative as a potent PFKFB3-targeted PET tracer.

Chen F, Wu Y, Ma Y, Yin H, Su F, Huang R, Wu X, Liu Q. Chen F, et al. Among authors: wu y, wu x. Front Chem. 2023 Mar 22;11:1158503. doi: 10.3389/fchem.2023.1158503. eCollection 2023. Front Chem. 2023. PMID: 37035116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,101 results

Search Page

Filters